This project targets a key “alarm system” inside brain immune cells that can keep inflammation going in MS: the cGAS–STING pathway. The team will use tiny, targeted particles (nanomedicines) carrying siRNA—a tool that can switch off a specific gene signal—to calm down overactive microglia (the brain’s resident immune cells). The goal is to reduce inflammation in the brain and spinal cord and support recovery.